Objective To evaluate new medical devices and drugs pertinent to otolaryngology–head and
neck surgery that were approved by the Food and Drug Administration (FDA) in 2021. Data …

Objective One minute of operating room (OR) time costs $36 to 37. However, ORs are
notoriously inefficient. There is growing literature on improving OR efficiency, but no formal …

Introduction Hypoglossal nerve stimulation was recently FDA approved for use in children
with Down Syndrome and persistent obstructive sleep apnea. Although there is a robust …

Objective: This study aims to define the incidence of infection with upper airway stimulation
(UAS) devices requiring explantation in a single academic center and identify factors that …

Objective To describe a novel lateral approach for hypoglossal nerve stimulator (HNS)
implantation in women and provide evidence for its safety and efficacy. Study Design …

Objective Hypoglossal nerve stimulation (HNS) can be an effective treatment for moderate to
severe obstructive sleep apnea (OSA) in positive airway pressure (PAP) intolerant patients …

Obstructive sleep apnea is a common chronic condition typically treated with positive airway
pressure. However, many patients have difficulty with adherence to this therapy, and for …

Objective No reported outcome measures have been established to evaluate sensor lead
function in the hypoglossal nerve stimulator (HNS). This study describes the development of …

Objective There have been case reports of adverse events of hypoglossal nerve stimulator
(HNS) implantation not seen in previous clinical trials, including pneumothorax and pleural …

Up to 80% of children with Down syndrome (DS) are affected by obstructive sleep apnea
(OSA), and only 16% to 30% will have resolution of their OSA with adenotonsillectomy …